Hepcidin - A novel biomarker with changing trends
Arunava Kali1★, Marie Victor Pravin Charles1, Rathan Shetty Kolkebail Seetharam2★ Corresponding author
- 1Departments of Microbiology, Mahatma Gandhi Medical College and Research Institute, Pillayarkuppam, Puducherry, INDIA.
- 2Otorhinolaryngology, Mahatma Gandhi Medical College and Research Institute, Pillayarkuppam, Puducherry, INDIA.
CORRESPONDENCE
Arunava Kali
Departments of Microbiology, Mahatma Gandhi Medical College and Research Institute, Pillayarkuppam, Puducherry, INDIA.
Received: 09-05-2014; Revised: 23-05-2014; Accepted: 05-05-2015.
Volume 9, Issue 17 · pp. 35–40 · PUBLISHED · DOI: 10.4103/0973-7847.156333
View on Pharmacogn. Rev. original site ↗
ABSTRACT
Hepcidin is a novel peptide hormone of hepatic origin. It has a crucial role in iron metabolism. The causative association of this peptide in anemia and iron overloading states has been well established. Current research has expanded the diagnostic implications of hepcidin in other medical conditions. Increased serum hepcidin has been reported in neoplastic diseases, inflammation, and sepsis. However, the clinical use of hepcidin as a biomarker is limited owing to nonavailability of an appropriate diagnostic test. Assays for serum and urine hepcidin estimation have been developed recently, which are likely to facilitate the use of hepcidin in research as well as in patient care in the near future.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Kali, A., Charles, M. V. P., & Seetharam, R. S. K. (). Hepcidin - A novel biomarker with changing trends. Pharmacognosy Reviews, 9(17), 35–40. https://doi.org/10.4103/0973-7847.156333